This site is intended for health professionals only
Newsletter
Hospital Healthcare Europe
Login
Twitter
Linkedin
Facebook
Select Language
English
French
German
Italian
Spanish
News
Views
Reviews & Research
Clinical
Cardiovascular
Dermatology
Gastroenterology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Sponsored
Clinical Excellence
Cardiology
Respiratory
Events
News
Views
Reviews & Research
Clinical
Cardiovascular
Dermatology
Gastroenterology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Sponsored
Clinical Excellence
Cardiology
Respiratory
Events
Home
>
Hepatology
Hepatology
500 million people await World Health Assembly decision on viral hepatitis
World Hepatitis Alliance launches first major policy report on viral hepatitis
Phase 2 telaprevir data presented at EASL
Patients achieve sustained viral response with a telaprevir-based regimen
Study shows a need for therapeutic options
Liver failure drug extension bid
FDA go-ahead for Salix-made Xifaxan
Needles and hearts
FDA recommends Xifaxan for approval
FDA warning over HIV drugs use
Novartis gains exclusive rights to Debio 025
HIV drug linked to liver condition
« Previous
1
…
4
5
6
7
8
9
Next »
Most read
1
Transcranial magnetic stimulation brain connectivity changes in major depression visible on MRI scan
by Rod Tucker
2
Oral vitamin A could become an alternative to isotretinoin for acne
by Rod Tucker
3
Amino acids supplement reduces muscle wasting and improves gut function in critically ill
by Rod Tucker
4
Less than two-thirds of patients alive 10 years after out-of-hospital cardiac arrest
by Rod Tucker
5
Launch of the new Hospital Pharmacy Europe Mobile App
by aporter2
Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
x
Search for: